Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/1998
08/26/1998EP0859778A2 Chemical compounds
08/26/1998EP0859777A1 8-azabicyclo 3.2.1]oct-2-ene derivatives, their preparation and use
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
08/26/1998EP0859638A1 Method for inhibiting cell-mediated killing of target cells
08/26/1998EP0859608A1 Treating niddm with rxr agonists
08/26/1998EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
08/26/1998CN1191135A Hypolipemic and its preparing process
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798375 Treatment of arteriosclerosis and xanthoma
08/25/1998US5798372 Method for preventing onset of restenosis after angioplasty employing a retinoid
08/25/1998US5798366 Treating genetic disorder by administering a 1,5-iminosugar
08/25/1998US5798362 Useful as alpha-adrenoreceptor blockers; condensation
08/25/1998US5798353 Treating eating disorder, obesity, diabetes, psychological disorder, sexual disorder, psychosis, memory disorder
08/25/1998US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer
08/25/1998US5798337 Low molecular weight peptidomimetic growth hormone secretagogues
08/25/1998US5798225 Process for recombinant production of PTH and PTHrp analogs
08/25/1998US5798102 Beta-amyloyd, streptolysin o, growth hormone
08/25/1998US5798101 Herbal appetite suppressant and weight loss composition
08/25/1998CA2160440C Method of manufacturing non-absorbable synthetic sulfated polysaccharides
08/25/1998CA2122479C Risedronate delayed-release compositions
08/25/1998CA2086247C Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
08/25/1998CA2006723C Sulfur-containing heterocyclic compounds
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998036062A1 Neural cell adhesion molecule splicing variants
08/20/1998WO1998036002A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035959A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035957A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998WO1998035956A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035952A1 Oxiran carboxylic acids for the treatment of diabetes
08/20/1998WO1998035944A1 Amides as npy5 receptor antagonists
08/20/1998WO1998035941A1 New benzolactam derivatives and medicinal compositions containing the same
08/20/1998WO1998035937A1 Cetp activity inhibitors
08/20/1998WO1998035674A1 Compositions for the inhibition of bone resorption
08/20/1998WO1998035667A1 Use of nitric oxid synthase inhibitors for the treatment of diabetes
08/20/1998DE19705963A1 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung Networked vinyl polymers with bile acid Adsorberwirkung
08/20/1998DE19705718A1 Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände New oxiranecarboxylic for the treatment of type 2 diabetes and other insulin-resistant states
08/20/1998CA2281602A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/20/1998CA2280871A1 Use of nitric oxide synthase inhibitors for the treatment of diabetes
08/20/1998CA2280722A1 Compositions for the inhibition of bone resorption
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2251580A1 Amides as npy5 receptor antagonists
08/20/1998CA2251368A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858340A1 Combination therapy for the treatment of diabetes and obesity
08/19/1998EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858335A1 2-alkylpyrrolidines
08/19/1998EP0667860B1 Aza spiro alkanes derivatives as therapeutic agents
08/19/1998CN1190957A Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino) carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190956A Novel process for the production of amorphous £R-(R*,R*)|-2-(4-fluorophenyl)-'beta', 'delta'-dihydroxy-5-(1-methylethyl)-3-phenyl-4-£(phenylamino) carbonyl|-1H-pyrrole-1-heptanoic acid calcium ......
08/19/1998CN1190955A Crystalline £R-(R',R')|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl|-1H-pyrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795899 Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl) pyrimidine-5-carboxylic acid N-methyl-N-(3-trifluoromethylphenyl)-amide, a process for the preparation thereof, the use thereof as pharmaceuticals and starting materials
08/18/1998US5795887 Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
08/18/1998US5795886 Anticonvulsants
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998US5795576 Chemical composition for aiding the absorption, binding and elimination of undigested fat
08/18/1998US5795570 Method of containing core material in microcapsules
08/18/1998CA2085008C Calcium citrate malate composition
08/18/1998CA1340007C Linear analogs of atrial natruiretic peptides
08/13/1998WO1998034920A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034895A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034647A1 Arginine silicate inositol complex and use thereof
08/13/1998WO1998034630A1 Use of gastrointestinal lipase inhibitors
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034625A1 Substance and method for reduction of lipids and cholesterol
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034607A1 Tetrahydrolipstatin containing compositions
08/13/1998WO1998024888A3 Polypeptides encoded by a human lipase-like gene, compositions and methods
08/13/1998CA2280507A1 Substance and method for reduction of lipids and cholesterol
08/13/1998CA2279636A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2279233A1 Arginine silicate complex and use thereof
08/13/1998CA2278854A1 Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes
08/12/1998EP0857725A1 (N-(pyridinylmethyl)-heterocyclic)-ylideneamine compounds as nicotinic acetylcholine receptor binding agents
08/12/1998EP0857483A1 Substituted aminopyridines in the treatment of glucose metabolism disorders
08/12/1998EP0857428A2 Dietetic soy based products and method for production thereof
08/12/1998EP0857175A1 Novel human cysteine protease
08/12/1998EP0650474B1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
08/12/1998CN1190438A Chimeric proteins for use in transport of selected substance into cells
08/12/1998CN1190394A Bicyclic-aromatic compound
08/11/1998US5792870 2-amino-3-aroyl-benzo β!thiophenes and methods for preparing and using same to produce 6-hdyroxy-2-(4-hydroxyphenyl)-3- 4-(2-aminoethoxy)-benzoyl!benzo β!thiophenes
08/11/1998US5792790 Method for improving weight gain and feed utilization in livestock
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792777 Biphenyl quinuclidines
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
08/11/1998US5792762 Dihydrobenzofluorene compounds, intermediates, compositions and methods
08/11/1998US5792747 Amino acid sequences
08/11/1998US5792745 Use of peptides for altering bone resorption
08/11/1998US5792503 Production of isoflavone enriched fractions from soy protein extracts
08/11/1998US5792461 Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
1 ... 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 ... 1298